Trials / Completed
CompletedNCT00660413
Comparison of Acceleromyography (AMG) and Mechanomyography (MMG) for Establishing Potency of Neuromuscular Blocking Agents
Comparison of Acceleromyography and Mechanomyography for Establishing Potency of Neuromuscular Blocking Agents, A Randomized Controlled Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Rigshospitalet, Denmark · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to compare two methods for neuromuscular monitoring, acceleromyography and mechanomyography for establishing the dose-response relationship and the potency of a neuromuscular blocking agent using rocuronium as an example. We hypothesized that there would be no significant difference between potencies estimated using acceleromyography and mechanomyography.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TOF-Watch SX (Acceleromyography) | Randomization of AMG to dominant or non-dominant arm. MMG at contralateral arm. |
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2008-02-01
- Completion
- 2008-02-01
- First posted
- 2008-04-17
- Last updated
- 2008-04-17
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00660413. Inclusion in this directory is not an endorsement.